Dosage & Administration:
• Patients not currently taking an Angiotensin Converting Enzyme (ACE) inhibitor or an Angiotensin II Receptor Blocker (ARB) or previously taking a low dose of these agents
• Patients with severe renal impairment
• Patients with moderate hepatic impairment
Dose should be doubled after 2 to 4 weeks to the target maintenance dose of 97/103 mg (Sacubitril/Valsartan) twice-daily, as tolerated by the patient.
Valmor 100 Tablet: Each film coated tablet contains Sacubitril Valsartan Sodium Hemipentahydrate equivalent to Sacubitril INN 49 mg and Valsartan USP 51 mg.